Screener
Cardiol Therapeutics
CRDLCardiol Therapeutics is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO David G. Elsley, with a market cap of $125.2M.
$125.16M+20.9%
We’re still putting together Cardiol Therapeutics’s detailed financials. Its latest earnings are below. You’ll find its full filings on SEC EDGAR, or explore the companies we cover.
Ask us to move Cardiol Therapeutics up the queue, and we’ll analyze its filings next.
Earnings
Next report
Date not yet announcedProfile
CountryCanada
Listed2019
Employees17.0
CEODavid G. Elsley
SectorHealthcare
Websitecardiolrx.com
FilingsSEC EDGAR